Related Experiment Videos
Isolated familial somatotropinoma
Beatriz Santana Soares1, Lawrence A Frohman
1Section of Endocrinology and Metabolism, University of Illinois at Chicago, IL 60612, USA.
Pituitary
|March 12, 2005
Summary
Isolated familial somatotropinomas (IFS) are rare genetic growth hormone (GH)-secreting pituitary tumors. These tumors manifest earlier than sporadic forms and are linked to chromosome 11q13.1-13.3.
Area of Science:
- Endocrinology
- Genetics
- Oncology
Background:
- Most growth hormone (GH)-secreting pituitary tumors are sporadic.
- A small subset exhibits familial aggregation, including Multiple Endocrine Neoplasia type 1 (MEN1), Carney Complex, or Isolated Familial Somatotropinomas (IFS).
- IFS represents familial GH-secreting pituitary tumors unassociated with other endocrine syndromes.
Purpose of the Study:
- To review clinical and genetic data of 46 families with Isolated Familial Somatotropinomas (IFS).
- To characterize the clinical presentation and genetic basis of familial GH-secreting pituitary tumors.
Main Methods:
- Review of clinical and genetic information from reported families with IFS.
- Analysis of tumor characteristics and inheritance patterns.
- Genetic linkage analysis to identify chromosomal regions associated with IFS.
Main Results:
- GH-secreting tumors in IFS typically occur at an earlier age compared to sporadic tumors.
- Earlier onset is particularly noted when affected family members belong to a single generation.
- Evidence suggests the IFS gene acts as a tumor suppressor, with loss of heterozygosity observed.
- Strong evidence for genetic linkage to a locus on chromosome 11q13.1-13.3 (less than 10 Mb).
Conclusions:
- Isolated Familial Somatotropinomas (IFS) represent a distinct genetic subtype of GH-secreting pituitary tumors.
- The genetic basis of IFS involves a tumor suppressor gene located on chromosome 11q13.1-13.3.
- Understanding the genetic underpinnings of IFS is crucial for early diagnosis and potential targeted therapies.